164 related articles for article (PubMed ID: 28218011)
1. Asymmetric dimethylarginine in the assessment of febrile neutropenia in hematological patients.
Lappalainen M; Hämäläinen S; Juutilainen A; Koivula I; Pulkki K; Jantunen E
Scand J Clin Lab Invest; 2017 Apr; 77(2):130-134. PubMed ID: 28218011
[TBL] [Abstract][Full Text] [Related]
2. IL-10 combined with procalcitonin improves early prediction of complications of febrile neutropenia in hematological patients.
Vänskä M; Koivula I; Jantunen E; Hämäläinen S; Purhonen AK; Pulkki K; Juutilainen A
Cytokine; 2012 Dec; 60(3):787-92. PubMed ID: 22902948
[TBL] [Abstract][Full Text] [Related]
3. Soluble CD14 as a Diagnostic and Prognostic Biomarker in Hematological Patients with Febrile Neutropenia.
Korpelainen S; Intke C; Hämäläinen S; Jantunen E; Juutilainen A; Pulkki K
Dis Markers; 2017; 2017():9805609. PubMed ID: 28845081
[TBL] [Abstract][Full Text] [Related]
4. High pentraxin 3 level predicts septic shock and bacteremia at the onset of febrile neutropenia after intensive chemotherapy of hematologic patients.
Vänskä M; Koivula I; Hämäläinen S; Pulkki K; Nousiainen T; Jantunen E; Juutilainen A
Haematologica; 2011 Sep; 96(9):1385-9. PubMed ID: 21880642
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of serum high-sensitivity procalcitonin and serum C-reactive protein tests for detecting bacterial infection in febrile neutropenia.
Aimoto M; Koh H; Katayama T; Okamura H; Yoshimura T; Koh S; Nanno S; Nishimoto M; Hirose A; Nakamae M; Nakane T; Nakamae H; Kakeya H; Hino M
Infection; 2014 Dec; 42(6):971-9. PubMed ID: 25038889
[TBL] [Abstract][Full Text] [Related]
6. Plasma copeptin in the assessment of febrile neutropenia.
Purhonen AK; Vänskä M; Hämäläinen S; Pulkki K; Lehtikangas M; Kuittinen T; Nousiainen T; Koivula I; Jantunen E; Juutilainen A
Peptides; 2012 Jul; 36(1):129-32. PubMed ID: 22580173
[TBL] [Abstract][Full Text] [Related]
7. Asymmetric dimethylarginine and L-arginine levels in neonatal sepsis and septic shock.
Aydemir O; Ozcan B; Yucel H; Bas AY; Demirel N
J Matern Fetal Neonatal Med; 2015 May; 28(8):977-82. PubMed ID: 24983667
[TBL] [Abstract][Full Text] [Related]
8. Serum caspase-cleaved cytokeratin-18 fragment as a prognostic biomarker in hematological patients with febrile neutropenia.
Intke C; Korpelainen S; Lappalainen M; Vänskä M; Hämäläinen S; Pulkki K; Jantunen E; Juutilainen A; Purhonen AK
Clin Exp Med; 2022 Feb; 22(1):83-93. PubMed ID: 34255216
[TBL] [Abstract][Full Text] [Related]
9. Febrile neutropenia in patients with acute myeloid leukemia: Outcome in relation to qSOFA score, C-reactive protein, and blood culture findings.
Lappalainen M; Hämäläinen S; Romppanen T; Pulkki K; Pyörälä M; Koivula I; Jantunen E; Juutilainen A
Eur J Haematol; 2020 Dec; 105(6):731-740. PubMed ID: 32740997
[TBL] [Abstract][Full Text] [Related]
10. Procalcitonin versus C-Reactive Protein as a Biomarker for Prediction of Bacterial Infection in Children with Febrile Neutropenia in Acute Leukemia.
Nahar A; Jamal CY; Refat R; Chowdhury T; Akter S; Karim A; Rahman MA; Yeamin MB; Saha BK; Hossain F; Rabbany MA
Mymensingh Med J; 2023 Jan; 32(1):76-82. PubMed ID: 36594305
[TBL] [Abstract][Full Text] [Related]
11. Human plasma cell-free DNA as a predictor of infectious complications of neutropenic fever in hematological patients.
Purhonen AK; Juutilainen A; Vänskä M; Lehtikangas M; Lakkisto P; Hämäläinen S; Koivula I; Jantunen E; Pulkki K
Infect Dis (Lond); 2015 Apr; 47(4):255-9. PubMed ID: 25664374
[TBL] [Abstract][Full Text] [Related]
12. Circulating levels of advanced glycation end products (AGE) and interleukin-6 (IL-6) are independent determinants of serum asymmetric dimethylarginine (ADMA) levels in patients with septic shock.
Nakamura T; Sato E; Fujiwara N; Kawagoe Y; Suzuki T; Ueda Y; Yamada S; Shoji H; Takeuchi M; Ueda S; Matsui T; Adachi H; Okuda S; Yamagishi S
Pharmacol Res; 2009 Dec; 60(6):515-8. PubMed ID: 19450686
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of sTREM-1, IL-8, PCT, and CRP in febrile neutropenia after autologous stem cell transplantation.
Michel CS; Teschner D; Wagner EM; Theobald M; Radsak MP
Ann Hematol; 2017 Dec; 96(12):2095-2101. PubMed ID: 28920169
[TBL] [Abstract][Full Text] [Related]
14. Changes in the microbiological epidemiology of febrile neutropenia in autologous stem cell transplant recipients.
Rönkkö R; Juutilainen A; Koivula I; Vänskä M; Nousiainen T; Jantunen E; Hämäläinen S
Infect Dis (Lond); 2018 Jun; 50(6):436-442. PubMed ID: 29303041
[TBL] [Abstract][Full Text] [Related]
15. Dynamics of procalcitonin and bacteremia in neutropenic adults with acute myeloid leukemia.
Gac AC; Parienti JJ; Chantepie S; Fradin S; Le Coutour X; Leclercq R; Reman O
Leuk Res; 2011 Oct; 35(10):1294-6. PubMed ID: 21831426
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with severe sepsis: prospective study of 94 neutropenic febrile episodes.
Jeddi R; Achour M; Amor RB; Aissaoui L; Bouterâa W; Kacem K; Lakhal RB; Abid HB; BelHadjAli Z; Turki A; Meddeb B
Hematology; 2010 Feb; 15(1):28-32. PubMed ID: 20132659
[TBL] [Abstract][Full Text] [Related]
17. Elevated asymmetric dimethylarginine levels predict short- and long-term mortality risk in critically ill patients.
Koch A; Weiskirchen R; Kunze J; Dückers H; Bruensing J; Buendgens L; Matthes M; Luedde T; Trautwein C; Tacke F
J Crit Care; 2013 Dec; 28(6):947-53. PubMed ID: 23953490
[TBL] [Abstract][Full Text] [Related]
18. [Procalcitonin as a predictor of bacteremia in pediatric patients with malignancies and febrile neutropenia].
Aliyev DA; Vezirova ZSh; Geyusheva TF
Klin Khir; 2015 Feb; (2):70-2. PubMed ID: 25985703
[TBL] [Abstract][Full Text] [Related]
19. Plasma level of interleukin-18 and complicated course of febrile neutropenia in hematological patients after intensive chemotherapy.
Korpelainen S; Hämäläinen S; Vänskä M; Koivula I; Pulkki K; Jantunen E; Juutilainen A; Purhonen AK
Cytokine; 2020 May; 129():155021. PubMed ID: 32087594
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of repeat blood cultures during febrile neutropenia in adult acute myeloid leukaemia patients undergoing intensive chemotherapy.
Kimura SI; Gomyo A; Hayakawa J; Tamaki M; Akahoshi Y; Harada N; Ugai T; Kusuda M; Kameda K; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Nakasone H; Kako S; Tanihara A; Kanda Y
Infect Dis (Lond); 2017 Oct; 49(10):748-757. PubMed ID: 28631944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
